Aravive, Inc.
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets…
Biotechnology
US, Houston [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Aravive, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAravive, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Aravive, Inc..
If you want to see a demo, head over to the financial segments of AAPL